Jooyeon J. Im

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Hyeonseok S. Jeong

> Home > Persons > Jooyeon J. Im

Publications

2019
[j3]
- view
  authority control:
- export record
  dblp key:
  - journals/imst/ImJOCSL19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/imst/ImJOCSL19
Jooyeon J. Im, Hyeonseok S. Jeong, Jin Kyoung Oh, Yong-An Chung, In-Uk Song, Kwang-Soo Lee:
Effects of nicergoline treatment on regional cerebral blood flow in early Alzheimer's disease. Int. J. Imaging Syst. Technol. 29(3): 323-328 (2019)
2018
[j2]
- view
  authority control:
- export record
  dblp key:
  - journals/imst/JangICCJK18
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/imst/JangICCJK18
Kyung-Sool Jang, Jooyeon J. Im, Yong-An Chung, Sung Woo Chung, Hyeonseok S. Jeong, Minwook Kim:
Assessment of cerebral blood perfusion changes after neurorehabilitation therapy in patients with middle cerebral artery infarction: An acetazolamide-challenged SPECT study. Int. J. Imaging Syst. Technol. 28(1): 15-20 (2018)
2017
[j1]
- view
  authority control:
- export record
  dblp key:
  - journals/imst/ChonJIOKCK17
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/imst/ChonJIOKCK17
Younghoon Chon, Hyeonseok S. Jeong, Jooyeon J. Im, Jin Kyoung Oh, Youngdo Kim, Yong-An Chung, Dai-Jin Kim:
Alterations of regional cerebral blood flow after NMDA receptor antagonist administration in patients with alcohol-related dementia. Int. J. Imaging Syst. Technol. 27(4): 376-382 (2017)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.